Chirogate is a professional Prostaglandin manufacturer.
01 1Chirogate International
02 1EUROAPI
03 1LGM Pharma
04 1Dr. Reddy's Laboratories
05 1TAPI Technology & API Services
06 2Apotex Pharmachem
07 1Catalent Pharma Solutions
08 1Dr Pradeep Reddy’s Laboratories Private Limited
09 1Everlight Chemical
10 1Kyowa Pharma Chemical Co Ltd
11 1MSN Laboratories
12 1PHF SA
13 2R TECH UENO LTD
14 1Sun Pharmaceutical Industries Limited
15 1Yonsung Fine Chemicals
16 1Zhejiang Ausun Pharmaceutical
17 1Zhejiang Tiantai Pharmaceutical
01 2Canada
02 2China
03 1France
04 4India
05 1Israel
06 3Japan
07 1South Korea
08 1Switzerland
09 2Taiwan
10 2U.S.A
01 8Active
02 4Inactive
03 7Blank
01 19Blank
01 1222MF10205
02 1224MF10099
03 1304MF10149
04 1305MF10013
05 15Blank
01 1WC-0168
02 1WC-0349
03 17Blank
NDC Package Code : 68245-0011
Start Marketing Date : 2010-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-04-11
Pay. Date : 2013-12-19
DMF Number : 24705
Submission : 2011-03-29
Status : Active
Type : II
NDC Package Code : 71796-041
Start Marketing Date : 2011-03-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23402
Submission : 2009-12-23
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18091
Submission : 2005-02-18
Status : Active
Type : II
Registration Number : 224MF10099
Registrant's Address : 1-11-1 Marunouchi, Chiyoda-ku, Tokyo
Initial Date of Registration : 2012-05-15
Latest Date of Registration : --
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-10-06
Pay. Date : 2016-08-16
DMF Number : 30802
Submission : 2016-08-08
Status : Active
Type : II
NDC Package Code : 76397-012
Start Marketing Date : 2020-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37281
Submission : 2022-08-24
Status : Active
Type : II
Registration Number : 305MF10013
Registrant's Address : 207, Sujeong-ro, Jangan-myeon, Hwaseong-si, Gyeonggi-do, 18581, Republic of Korea
Initial Date of Registration : 2023-02-02
Latest Date of Registration : --
NDC Package Code : 40016-014
Start Marketing Date : 2022-06-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-04-27
Pay. Date : 2018-02-09
DMF Number : 32472
Submission : 2018-03-30
Status : Active
Type : II
Date of Issue : 2022-08-08
Valid Till : 2025-07-14
Written Confirmation Number : WC-0168
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24286
Submission : 2010-11-08
Status : Inactive
Type : II
We have 17 companies offering Lubiprostone
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?